Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-Term Therapy With Ribavirin for Chronic Hepatitis C
NCT00001854Phase 4Completed
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases
- Start
- Feb 1999
- Primary completion
- Oct 2007
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ribavirin in hepatitis C (HCV), sponsored by National Institute of Diabetes and Digestive and Kidney Diseases. Primary endpoint: Degree of histologic improvement on liver biopsy at 8 years. Started Feb 1999; status: completed.
02
Drugs
ribavirin
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT00001854.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00001854.